NeoGenomics Inc (NEO)
Healthcare
Diagnostics & Research
15.30 $
-3.7%
vs. previous close
Closing price · As of: 31. Jul 2026
Who owns NeoGenomics Inc (NEO)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 90.7% of the shares are freely tradable; institutional investors hold 108.4%.
Ownership Structure
Institutional ownership
Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
108.4%
Insiders
Share of the stock held by the executives, founders and major shareholders of the company itself.
2.1%
Float
Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
90.7%
Short % of float
Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
12.4%
Shares Outstanding
Total number of shares issued. Price times share count gives market cap.
129Mio.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| BlackRock Inc | 15.53 | 19,957,502 | +2.5 | 03/31/2026 |
| First Light Asset Management, LLC | 7.57 | 9,729,978 | -3.0 | 03/31/2026 |
| Greenhouse Funds LLLP | 7.08 | 9,100,103 | +5.3 | 03/31/2026 |
| Vanguard Portfolio Management, LLC | 5.93 | 7,622,187 | +0.0 | 03/31/2026 |
| First Trust Advisors L.P. | 4.80 | 6,162,371 | +0.0 | 03/31/2026 |
| Vanguard Capital Management, LLC | 4.40 | 5,655,823 | +0.0 | 03/31/2026 |
| BRAIDWELL LP | 4.37 | 5,617,402 | +21.3 | 03/31/2026 |
| State Street Corp | 3.99 | 5,119,838 | +2.8 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| iShares Core S&P Small-Cap ETF | 6.18 | 7,939,402 | +0.0 | 07/28/2026 |
| First Trust NYSE Arca Biotech ETF | 5.06 | 6,504,773 | +0.0 | 07/29/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.